問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2025-08-20

曾漢儀
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2020-05-18 - 2023-12-31

Phase III

Active
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated Recurrent Urinary Tract Infections (rUTIs) in Women
  • Condition/Disease

    Recurrent Urinary Tract Infections (rUTIs)

  • Test Drug

    U101

Participate Sites
19Sites

Not yet recruiting7Sites

Recruiting6Sites

Terminated6Sites

2024-06-01 - 2030-12-31

Phase II/III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Not yet recruiting6Sites

Recruiting1Sites

2017-09-04 - 2019-08-31

Phase IV

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites